Mercapturic acid urinary metabolites of 3-butene-1,2-diol as in vivo evidence for the formation of hydroxymethylvinyl ketone in mice and rats

Chemical Research in Toxicology

Volumn 17, Issue 6, 2004, Pages 819-826

  Sprague, Christopher L ^a   Elfarra, Adnan A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BUTADIENE; 2 BUTANONE; 3 BUTENE 1,2 DIOL; 4 (N ACETYLCYSTEINYL) 1 HYDROXY 2 BUTANONE; ACETYLCYSTEINE; CARBOXYL GROUP; HYDROXYL GROUP; HYDROXYMETHYLVINYL KETONE; UNCLASSIFIED DRUG; VINYL DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; DOSE RESPONSE; ESTERIFICATION; GAS CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; METABOLITE; MOUSE; NONHUMAN; RAT; REDUCTION; SILYLATION; URINE LEVEL;

ACETYLCYSTEINE; ANIMALS; BUTADIENES; BUTANONES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLYCOLS; MALE; MICE; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 3042768116     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx049949f     Document Type: Article

References (32)

1. Brunneman, K. D., Kagan, M. R., Cox, J. E., and Hoffman, D. (1990) Analysis of 1,3-butadiene and other selected gas-phase components in cigarette mainstream and sidestream smoke by gas chromatography-mass selective detection. Carcinogenesis 11, 1863-1868.
2. Hughes, K., Meek, M. E., Walker, M., and Beauchamp, R. (2003) 1,3-Butadiene: exposure estimation, hazard characterization, and exposure-response analysis. J. Toxicol. Environ. Health, Part B 6, 55-83.
3. Santos-Burgoa, C., Matanoski, G. M., Zeger, S., and Schwartz, L. (1992) Lymphohematopoietic cancer in styrene-butadiene polymerization workers. Am. J. Epidemiol. 136, 843-854.
4. Owen, P. E., Glaister, J. R., Gaunt, I. F., and Pullinger, D. H. (1987) Inhalation toxicity studies with 1,3-butadiene: 3 two year toxicity/ carcinogenicity study in rats. Am. Ind. Hyg. Assoc. J. 48, 407-413.
5. 1 mice at low exposure concentrations. Cancer Res. 50, 6592-6599.
6. Csanady, G. A., Guengerich, F. P., and Bond J. A. (1992) Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats, and mice. Carcinogenesis 13, 1143-1153.
7. Duescher, R. J., and Elfarra, A. A. (1994) Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: evidence for major roles by cytochrome P450 2A6 and 2E1. Arch. Biochem. Biophys. 311, 339-342.
8. Krause, R. J., and Elfarra, A. A. (1997) Oxidation of butadiene monoxide to meso and (±)-diepoxybutane by cDNA-expressed human cytochrome P450s and by mouse, rat, and human liver microsomes: evidence for preferential hydration of meso-diepoxybutane in rat and human liver microsomes. Arch. Biochem. Biophys. 337, 176-184.
9. Krause, R. J., Sharer, J. E., and Elfarra, A. A. (1997) Epoxide hydrolase-dependent metabolism of butadiene monoxide to 3-butene-1,2-diol in mouse, rat, and human liver. Drug Metab. Dispos. 25, 1013-1015.
10. 13C]-butadiene. Chem. Res. Toxicol. 9, 764-773.
11. Bechtold, W. E., Strunk, M. R., Chang, I. Y., Ward, J. B., and Henderson, R. F. (1994) Species differences in urinary butadiene metabolites: Comparisons of metabolite ratios between mice, rats, and humans. Toxicol. Appl. Pharmacol. 127, 44-49.
12. Sprague, C. L., and Elfarra, A. A. (2003) Detection of carboxylic acids and inhibition of hippuric acid formation in rats treated with 3-butene-1,2-diol, a major metabolite of 1,3-butadiene. Drug Metab. Dispos. 31, 986-992.
13. Kemper, R. A., Elfarra, A. A., and Myers, S. R. (1998) Metabolism of 3-butene-1,2-diol in B6C3F1 mice: Evidence for involvement of alcohol dehydrogenase and cytochrome P450. Drug Metab. Dispos. 26, 914-920.
14. Sprague, C. L., Phillips, L. A., Young, K. M., and Elfarra, A. A. (2004) Species and tissue differences in the toxicity of 3-butene-1,2-diol in male Sprague-Dawley rats and B6C3F1 mice. Toxicol. Sci. In press.
15. Krause, R. J., Kemper, R. A., and Elfarra, A. A. (2001) Hydroxymethylvinyl ketone: a reactive Michael acceptor formed by the oxidation of 3-butene-1,2-diol by cDNA expressed human cytochrome P450s and mouse, rat, and human liver microsomes. Chem. Res. Toxicol. 14, 1590-1595.
16. Sabourin, P. J., Burka, L. T., Bechtold, E., Dahl, A. R., Hoover, M. D., Chang, I. Y., and Henderson, R. F. (1992) Species differences in urinary butadiene metabolites; identification of 1,2-dihydroxy-4-(n-acetylcysteinyl) butane, a novel metabolite of butadiene. Carcinogenesis 13, 1633-1638.
17. 14C]-1,3-butadiene in rats and mice: relevance to cancer susceptibility. Toxicol. Sci. 49, 186-201.
18. Albertini, R. J., et al. (2003) Biomarkers in Czech workers exposed to 1,3-butadiene: a transitional epidemiological study. Health Effects Inst. Res. Rep. 116, 43-61.
19. Hayes, R. B., Zhang, L., Yin, S., Swenberg, J. A., Xi, L., Wiencke, J., Bechtold, W. E., Yao, M., Rothman, N., Haas, R., O'Neil, J. P., Zhang, D., Wiemels, J., Dosemeci, M., Li, G., and Smith, M. T. (2000) Genotoxic markers among butadiene polymer workers in China. Carcinogenesis 21, 55-62.
20. Fustinoni, S., Soleo, L., Warhol, M., Begemann, P., Rannug, A., Neumann, H. G., Swenberg, J. A., Vimercati, L., Foa, V., and Colombi, A. (2002) Influence of metabolic genotypes on biomarkers of exposure to 1,3-butadiene in humans. Cancer Epidemiol. Biomarkers Prev. 11, 1082-1090.
21. Richardson, K. A., Peters, M. M. C. G., Megens, R. H. J. J. J., van Elburg, P. A., Golding, B. T., Boogard, P. J., Watson, W. P., and van Sittert, N. J. (1998) Identification of novel metabolites of butadiene monoepoxide in rats and mice. Chem. Res. Toxicol. 11, 1543-1555.
22. Kemper, R. A., and Elfarra, A. A. (1996) Oxidation of 3-butene-1,2-diol by alcohol dehydrogenase. Chem. Res. Toxicol. 9, 1127-1134.
23. Walsh, C. (1979) Decarboxylation of α-keto acids. In Enzymatic Reaction Mechanisms (Bartlett, A. C., and McCombs, L. W., Eds.) pp 682-702, W. H. Freeman and Company, San Francisco.
24. Swaminathan, S., and Narayanan, K. V. (1971) The Rupe and Meyer-Schuster rearrangements. Chem. Rev. 71, 429-438.
25. Ramu, K., Fraiser, L. H., Mamiya, B., Ahmed, T., and Kehrer, J. P. (1995) Acrolein mercapturic acids: synthesis, characterization, and assessment of their role in the bladder toxicity of cyclophosphamide. Chem. Res. Toxicol. 8, 515-524.
26. Ramu, K., Perry, C. S., Ahmed, T., Pakenham, G., and Kehrer, J. P. (1996) Studies on the basis for the toxicity of acrolein mercapturic acids. Toxicol. Appl. Pharmacol. 140, 487-498.
27. Krause, R. J., Glocke, S. C., and Elfarra, A. A. (2002) Sulfoxides as urinary metabolites of S-allyl-1-cysteine in rats: evidence for the involvement of flavin-containing monooxygenases. Drug Metab. Dispos. 30, 1137-1142.
28. Linhart, I., Franktik, L., Vodickova, M., Bosmanska, J., Smejkal, J., and Mitera, J. (1996) Biotransformation of acrolein in rat: excretion of mercapturic acids after inhalation and intraperitoneal injection. Toxicol. Appl. Pharmacol. 136, 155-160.
29. 2-Propanodeoxyguanosine adducts of the 1,3-butadiene metabolite, hydroxymethylvinyl ketone. Chem. Res. Toxicol. 16, 1448-1454.
30. Himmelstein, M. W., Turner, M. J., Asgharian, B., and Bond J. A. (1996) Metabolism of 1,3-butadiene: inhalation pharmacokinetics and tissue dosimetry of butadiene epoxides in rats and mice. Toxicology 113, 306-309.
31. Elfarra, A. A., Krause, R. J., Last, A. R., Lash, L. H., and Parker, J. C. (1998) Species- and sex-related differences in metabolism of trichloroethylene to yield chloral and trichloroethanol in mouse, rat, and human liver microsomes. Drug Metab. Dispos. 26, 779-785.
32. Bosron, W. F., and Li, T.-K. (1987) Catalytic properties of human liver alcohol dehydrogenase isoenzymes. Enzyme 37, 19-28.